Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radiofrequency Ablation-Reference-Cited by-同舟云学术

Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radiofrequency Ablation

Published:2018-05 Issue:2 Volume:287 Page:705-714
ISSN:0033-8419
Container-title:Radiology
language:en
Short-container-title:Radiology

Author:

Peng Zhenwei,Chen Shuling,Wei Mengchao,Lin Manxia,Jiang Chunlin,Mei Jie,Li Bin,Wang Yu,Li Jiaping,Xie Xiaoyan,Chen Minshan,Qian Guojun,Kuang Ming

Funder

National Natural Science Foundation of China

Publisher

Radiological Society of North America (RSNA)

Subject

Radiology Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/radiol.2018171541

Reference31 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. Surgical treatment of intra hepatic recurrence of hepatocellular carcinoma

3. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy

4. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

5. Sorafenib in Advanced Hepatocellular Carcinoma

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune-targeted therapy with transarterial chemo(embolization) for unresectable HCC: a systematic review and meta-analysis;Frontiers in Immunology;2024-08-02

2. Radiofrequency ablation combined with transcatheter arterial chemoembolization for recurrent liver cancer;World Journal of Gastrointestinal Surgery;2024-06-27

3. Efficacy of Lenvatinib Combined with PD-1 Inhibitor versus Sorafenib and PD-1 Inhibitor with or Without TACE for Hepatocellular Carcinoma with Extrahepatic Metastasis;ImmunoTargets and Therapy;2024-05

4. Transarterial chemoembolization with molecular targeted therapies plus camrelizumab for recurrent hepatocellular carcinoma;BMC Cancer;2024-03-27

5. Efficacy of radiation plus transarterial chemoembolization and lenvatinib in hepatocellular carcinoma with portal vein tumor thrombus;Frontiers in Oncology;2023-12-19